Study: How Cost And Timeline Uncertainty Plague Medtech In The EU

 
• By Amanda Maxwell

EU study underscores need for reform in predictability, transparency, and cost-efficiency to enhance Europe’s competitiveness and strengthen its global role in health care.

Balancing time and money
Time and costs are both major considerations for medtech manufacturers weighing up the EU market • Source: Shutterstock

More from Medtech Insight

More from Policy & Regulation